Immatics N.V. Files Q2 2025 6-K Report
Ticker: IMTX · Form: 6-K · Filed: Aug 13, 2025 · CIK: 1809196
Sentiment: neutral
Topics: financial-update, collaboration, biotech
TL;DR
Immatics 6-K filed: Q2 2025 financials out, shows R&D spend and updates on Genmab/Moderna deals.
AI Summary
Immatics N.V. filed a 6-K report for the period ending June 30, 2025. The filing includes financial data for the second quarter of 2025, detailing expenses such as Research and Development and General and Administrative costs. It also references collaboration agreements with companies like Genmab and Moderna.
Why It Matters
This filing provides investors with an update on Immatics' financial position and ongoing collaborations, crucial for assessing the company's progress in the biotechnology sector.
Risk Assessment
Risk Level: medium — Biotech companies like Immatics are inherently risky due to the long development cycles and high failure rates of drug candidates.
Key Numbers
- Q2 2025 — Reporting Period (Financials and operational updates are for this period.)
- June 30, 2025 — As of Date (The report reflects the company's status on this date.)
Key Players & Entities
- Immatics N.V. (company) — Filer of the report
- Genmab (company) — Party to a collaboration agreement
- Moderna (company) — Party to a collaboration agreement
FAQ
What were Immatics' Research and Development expenses for the period ending June 30, 2025?
The filing indicates Research and Development Expenses for the period from April 1, 2024, to June 30, 2024, but specific figures for the Q2 2025 period are not detailed in the provided snippet.
What is the nature of the collaboration agreement with Genmab?
The filing mentions a 'Genmab Collaboration Agreement' for the periods April 1, 2024, to June 30, 2024, and April 1, 2025, to June 30, 2025, but does not specify the terms or financial details.
What is the nature of the collaboration agreement with Moderna?
The filing references a 'Moderna Collaboration Agreement' for the period April 1, 2025, to June 30, 2025, without providing specific details on the agreement's nature or financial implications.
What is Immatics' fiscal year end?
Immatics N.V.'s fiscal year ends on December 31.
When was Immatics N.V. formerly known as Immatics B.V.?
The company changed its name from Immatics B.V. to Immatics N.V. on April 13, 2020.
Filing Stats: 377 words · 2 min read · ~1 pages · Grade level 8.5 · Accepted 2025-08-13 07:06:23
Filing Documents
- imtx-20250630.htm (6-K) — 119KB
- imtx-ex99_1.htm (EX-99.1) — 2230KB
- imtx-ex99_2.htm (EX-99.2) — 596KB
- imtx-ex99_3.htm (EX-99.3) — 73KB
- img262971710_0.jpg (GRAPHIC) — 21KB
- imtx-ex99_3s1.jpg (GRAPHIC) — 316KB
- imtx-ex99_3s2.jpg (GRAPHIC) — 717KB
- imtx-ex99_3s3.jpg (GRAPHIC) — 459KB
- imtx-ex99_3s4.jpg (GRAPHIC) — 443KB
- imtx-ex99_3s5.jpg (GRAPHIC) — 397KB
- imtx-ex99_3s6.jpg (GRAPHIC) — 406KB
- imtx-ex99_3s7.jpg (GRAPHIC) — 379KB
- imtx-ex99_3s8.jpg (GRAPHIC) — 359KB
- imtx-ex99_3s9.jpg (GRAPHIC) — 207KB
- imtx-ex99_3s10.jpg (GRAPHIC) — 329KB
- imtx-ex99_3s11.jpg (GRAPHIC) — 481KB
- imtx-ex99_3s12.jpg (GRAPHIC) — 396KB
- imtx-ex99_3s13.jpg (GRAPHIC) — 386KB
- imtx-ex99_3s14.jpg (GRAPHIC) — 444KB
- imtx-ex99_3s15.jpg (GRAPHIC) — 426KB
- imtx-ex99_3s16.jpg (GRAPHIC) — 424KB
- imtx-ex99_3s17.jpg (GRAPHIC) — 301KB
- imtx-ex99_3s18.jpg (GRAPHIC) — 504KB
- imtx-ex99_3s19.jpg (GRAPHIC) — 337KB
- imtx-ex99_3s20.jpg (GRAPHIC) — 383KB
- imtx-ex99_3s21.jpg (GRAPHIC) — 451KB
- imtx-ex99_3s22.jpg (GRAPHIC) — 205KB
- imtx-ex99_3s23.jpg (GRAPHIC) — 406KB
- imtx-ex99_3s24.jpg (GRAPHIC) — 403KB
- imtx-ex99_3s25.jpg (GRAPHIC) — 352KB
- imtx-ex99_3s26.jpg (GRAPHIC) — 545KB
- imtx-ex99_3s27.jpg (GRAPHIC) — 518KB
- imtx-ex99_3s28.jpg (GRAPHIC) — 490KB
- imtx-ex99_3s29.jpg (GRAPHIC) — 445KB
- imtx-ex99_3s30.jpg (GRAPHIC) — 197KB
- imtx-ex99_3s31.jpg (GRAPHIC) — 353KB
- imtx-ex99_3s32.jpg (GRAPHIC) — 351KB
- imtx-ex99_3s33.jpg (GRAPHIC) — 360KB
- imtx-ex99_3s34.jpg (GRAPHIC) — 467KB
- imtx-ex99_3s35.jpg (GRAPHIC) — 418KB
- imtx-ex99_3s36.jpg (GRAPHIC) — 378KB
- imtx-ex99_3s37.jpg (GRAPHIC) — 198KB
- imtx-ex99_3s38.jpg (GRAPHIC) — 258KB
- imtx-ex99_3s39.jpg (GRAPHIC) — 308KB
- imtx-ex99_3s40.jpg (GRAPHIC) — 453KB
- imtx-ex99_3s41.jpg (GRAPHIC) — 389KB
- imtx-ex99_3s42.jpg (GRAPHIC) — 470KB
- imtx-ex99_3s43.jpg (GRAPHIC) — 283KB
- imtx-ex99_3s44.jpg (GRAPHIC) — 457KB
- imtx-ex99_3s45.jpg (GRAPHIC) — 327KB
- imtx-ex99_3s46.jpg (GRAPHIC) — 332KB
- imtx-ex99_3s47.jpg (GRAPHIC) — 399KB
- 0001193125-25-179419.txt ( ) — 37029KB
- imtx-20250630.xsd (EX-101.SCH) — 1806KB
- imtx-20250630_htm.xml (XML) — 2620KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMATICS N.V. Date: August 13, 2025 by: /s/ Harpreet Singh Harpreet Singh Chief Executive Officer 3